Access options
Subscribe to Journal
Get full journal access for 1 year
$259.00
only $21.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Cyranoski, D. Chinese genomics giant BGI plots commercial path. Nat Biotechnol 30, 1159–1160 (2012). https://doi.org/10.1038/nbt1212-1159
Published:
Issue Date:
Further reading
-
Diversity and inclusion in genomic research: why the uneven progress?
Journal of Community Genetics (2017)
-
Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia
Scientific Reports (2017)
-
Chinese investors tap US biotechs
Nature Biotechnology (2013)